(1S)-1,5-anhydro-2,3,4,6-tetra-O-acteyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofu-ran-3-yl]oxy]phenyl] methyl]phenyl]-D-Glucitol; Empagliflozin Intermediate
CAS: 915095-99-7
Chemical Formula:C31H35ClO11
Molecular Weight: 619.06
Availability: R&D; Commercialization
⬤ CAS No. 915095-99-7
⬤ Our Packaging type：
20kg barrel；5kg barrel；1kg bag；500g bag ; Customized Packaging
| Product Name | Acetoxy Empagliflozin |
| CAS No. | 915095-99-7 |
| Chemical Formula | C31H35ClO11 |
| Molecular Weight | 619.06 |
| EINECS | 1592732-453-0 |
| Related Categories | Empagliflozin Intermediate |
| Boiling Point | 673.8±55.0 °C(Predicted) |
| Density | 1.33±0.1 g/cm3(Predicted) |
| Note | Non-pharmaceutical, only used for industrial synthesis or research and development |
| Core Drug Synthesis | Key intermediates for Empagliflozin API；Used in the synthesis of SGLT2 inhibitor drugs |
Reliable Global Partner
“Tianming Pharmaceutical has redefined reliability for us. Their ability to deliver high-potency APIs and intermediates under tight deadlines—is unmatched. The team’s transparency in documentation and proactive updates make them a stress-free partner. A true backbone for our operations!”
March 18, 2024
Outstanding Technical Guidance
“Few suppliers align so perfectly with EU GMP requirements. Tianming’s commitment to audit-ready quality systems, batch traceability, and purity consistency has streamlined our production processes. Their diligence eliminates regulatory risks—a rare advantage in today’s market.”
February 15, 2024
Beyond Supplier, A Solutions Partner
“Tianming’s technical team doesn’t just deliver materials—they solve problems. When we faced stability challenges with a niche compound, their scientists proposed a tailored purity adjustment that saved our project timeline. Their agility transforms obstacles into opportunities.”
June 15, 2024
Strategic Growth Ally
“Over 5+ years, Tianming has consistently adapted to our evolving needs—whether scaling volumes or supporting custom synthesis projects. Their ethical pricing models and long-term vision make them more than a vendor; they’re integral to our competitive edge.”
April 27, 2024
Comparing Nifedipine & Amlodipine: Onset, duration, and side effects decoded. Demand for amlodipine intermediates? We deliver quality.
Hechi Vice Mayor Chen Zhijie toured Tianming Pharmaceutical’s facilities, praising its R&D strength and the “Jinan R&D + Hechi production” model.
This non-peptide GLP-1 receptor agonist, now in late-stage clinical trials, is redefining possibilities for diabetes and obesity treatment. Let’s unpack what makes it distinctive from both lab bench and manufacturing perspectives.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.
